Why pharmacokinetic differences among oral triptans have little clinical importance: a comment

By Ferrari Anna   Tiraferri Ilaria   Neri Laura   Sternieri Emilio  

The Journal of Headache and Pain, Vol. 12, Iss. 1, 2011-02 ,pp. : 5-12

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine

By Gentile Giovanna   Borro Marina   Lala Noemi   Missori Serena   Simmaco Maurizio   Martelletti Paolo  

The Journal of Headache and Pain, Vol. 11, Iss. 5, 2010-10 ,pp. : 431-435

Springer Publishing Company

Access to resources Recommend Favorite

Topiramate: efficacy and tolerability in children according to epilepsy syndromes

By Mikaeloff Y.   Saint-Martin A.d.   Mancini J.   Peudenier S.   Pedespan J.-M.   Vallee L.   Motte J.   Bourgeois M.   Arzimanoglou A.   Dulac O.   Chiron C.  

Epilepsy Research, Vol. 53, Iss. 3, 2003-03 ,pp. : 225-232

Elsevier

Access to resources Recommend Favorite

Citalopram in general practice: its efficacy and tolerability

By Wade A.   Rosenberg C.  

Primary Care Psychiatry, Vol. 7, Iss. 4, 2001-12 ,pp. : 123-128

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia

By Buckley P.F.   Goldstein J.M.   Emsley R.A.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite